nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.36485/1561-6274-2024-28-2-23-30QJXVTNnefr-2312Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESНеочевидные отдаленные последствия COVID-19 для почек. Обзор литературыUnobvious long-term effects of COVID-19 for kidneys. The literature reviewhttps://orcid.org/0000-0003-1773-9971ФедулкинаВ. А.FedulkinaV. A.

Старший научный сотрудник Федулкина Вероника Андреевна, канд. мед. наук

129110, Россия, Москва, ул. Щепкина, д. 61/2

Senior researcher Fedulkina Veronika Andreevna, MD, PhD

129110, Russia, Moscow, st. Shchepkina, 61/2

v.fedulkina@mail.ruhttps://orcid.org/0000-0002-6010-8975АртамоноваА. А.ArtamonovaA. A.

Старший научный сотрудник Артамонова Александра Анатольевна, канд. мед. наук

129110, Россия, Москва, ул. Щепкина, д. 61/2

Senior researcher Artamonova Alexandra Anatolyevna, Ph.D. n.

129110, Russia, Moscow, st. Shchepkina, 61/2

aartamonova@yandex.ruХирургическое отделение трансплантации почки, Московский областной научно-исследовательский клинический институт им. М.Ф. ВладимирскогоРоссияSurgical Department of Kidney Transplantation, Moscow Regional Research Clinical Institute named after. M.F. VladimirskyRussian Federation2024120720242822330Copyright © Федулкина В.А., Артамонова А.А., 20242024Федулкина В.А., Артамонова А.А.Fedulkina V.A., Artamonova A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/2312

Влияние COVID-19 на течение хронической болезни почек (ХБП) уже подтверждено исследователями всего мира. В основном, изучая поражение почек при COVID-19, авторы уделяют внимание новой коронавирусной инфекции в срезе именно развития острого повреждения почек (ОПП) или смертности от нее больных с уже имеющейся ХБП, особенно пациентов, получающих гемодиализ или имеющих трансплантированную почку, приводя анализ смертности, рисков и прогнозов. Однако до сих пор в публикациях отсутствует описание того, как данная инфекция может влиять на функцию почек, не имевших признаков ХБП до COVID-19. Особенно скудны в настоящее время исследования, посвященные анализу долгосрочных результатов наблюдения и лечения таких больных. В данном обзоре рассмотрены зарубежные и отечественные исследования, касающиеся как влияния хронических заболеваний почек на тяжесть течения коронавирусной инфекции, так и рисков развития заболеваний почек после перенесенного COVID-19, в том числе, с развитием острого повреждения почек и в долгосрочной перспективе. Такой подход способен подчеркнуть актуальность своевременного выявления среди больных COVID-19 пациентов с развивающейся хронической болезнью почек на ранних стадиях с целью их дальнейшего диспансерного наблюдения и своевременного назначения нефропротективной терапии.  Поиск источников литературы проводился с помощью PubMed, Science Direct, eLibrary по ключевым словам «коронавирус», «COVID-19», «SARS-CoV-2», «острое повреждение почек», «хроническая болезнь почек», «acute kidney injury», «chronic kidney disease» и их комбинациям с охватом публикаций с 2019 по 2023 г. на русском и английском языках.

The impact of COVID-19 on the course of chronic kidney disease (CKD) has already been confirmed by researchers around the world. Basically, studying kidney damage in COVID-19, the authors pay attention to the new coronavirus infection in terms of the development of acute kidney injury (AKI) or mortality from it in patients with existing CKD, especially patients receiving hemodialysis or having a transplanted kidney, providing an analysis of mortality, risks and forecasts. However, there is still no published description of how this infection can affect the function of kidneys that did not have signs of CKD before COVID-19. Currently, studies devoted to the analysis of long-term results of observation and treatment of such patients are especially scarce. The review examines foreign and domestic studies concerning both the influence of chronic kidney disease on the severity of coronavirus infection and the risks of developing kidney disease after COVID-19, including the development of acute kidney injury and in the long term. This approach can highlight the relevance of timely identification of patients with developing CKD in the early stages among patients with COVID-19 for the purpose of their further follow-up and timely prescription of nephroprotective therapy. The search for literature sources was carried out using PubMed, Science Direct, eLibrary using the keywords “coronavirus”, “COVID-19”, “SARS-CoV-2”, “acute kidney injury”, “chronic kidney disease” and their combinations covering publications from 2019 to 2023 in Russian and English.

COVID-19SARS-CoV-2коронавирусострое повреждение почекхроническая болезнь почекотдаленные последствияCOVID-19SARS-CoV-2coronavirusacute kidney injurychronic kidney diseaselong-term consequencesReferencesDegenaar A, Jacobs A, Kruger R et al. Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study. BMC Nephrol 2023;24(1):96. doi: 10.1186/s12882-023-03100-wDegenaar A, Jacobs A, Kruger R et al. Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study. BMC Nephrol 2023;24(1):96. doi: 10.1186/s12882-023-03100-wMajor RW, Cheng MRI, Grant RA et al. Сardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One 2018;13(3):e0192895. doi: 10.1371/journal.pone.0192895Major RW, Cheng MRI, Grant RA et al. Сardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One 2018;13(3):e0192895. doi: 10.1371/journal.pone.0192895Tangri N, Moriyama T, Schneider MP et al. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open 2023;13(5):e067386. doi: 10.1136/bmjopen-2022-067386Tangri N, Moriyama T, Schneider MP et al. Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open 2023;13(5):e067386. doi: 10.1136/bmjopen-2022-067386Jager KJ, Kovesdy C, Langham R et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019;96(5):1048–1050. doi: 10.1016/j.kint.2019.07.012Jager KJ, Kovesdy C, Langham R et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019;96(5):1048–1050. doi: 10.1016/j.kint.2019.07.012Power A, Sultan AA, Arnlov J. Inside CKD: projecting the future burden of chronic kidney disease in Europe using microsimulation modelling [poster]. Presented at: International Society of Nephrology World Congress of Nephrology (ISN-WCN) (Virtual Meeting); April 15–19, 2021Power A, Sultan AA, Arnlov J. Inside CKD: projecting the future burden of chronic kidney disease in Europe using microsimulation modelling [poster]. Presented at: International Society of Nephrology World Congress of Nephrology (ISN-WCN) (Virtual Meeting); April 15–19, 2021Kushner P, Peach E, Wittbrodt E et al. Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEALCKD study. Clin Kidney J 2021;15(4):738–746. doi: 10.1093/ckj/sfab235Kushner P, Peach E, Wittbrodt E et al. Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEALCKD study. Clin Kidney J 2021;15(4):738–746. doi: 10.1093/ckj/sfab235World Health Organization (WHO). Statistics on COVID-19 in Russian Federation. 15.08.2023 [Internet]. Available from: https://covid19.who.int/region/euro/country/ruWorld Health Organization (WHO). Statistics on COVID-19 in Russian Federation. 15.08.2023 [Internet]. Available from: https://covid19.who.int/region/euro/country/ruWu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239–1242. doi: 10.1001/jama.2020.2648Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239–1242. doi: 10.1001/jama.2020.2648CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 – United States. February 12 – March 28. Weekly 2020;69(13):382–386. doi:10.15585/mmwr.mm6913e2CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 – United States. February 12 – March 28. Weekly 2020;69(13):382–386. doi:10.15585/mmwr.mm6913e2Guan WJ, Ni ZY, Hu Y et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032Guan WJ, Ni ZY, Hu Y et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032COVID-19 Surveillance Group. Characteristics of COVID-19 patients dying in Italy: report based on available data on March 20th, 2020. Rome, Italy: Instituto Superiore Di Sanita; 2020 [Internet]. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdfCOVID-19 Surveillance Group. Characteristics of COVID-19 patients dying in Italy: report based on available data on March 20th, 2020. Rome, Italy: Instituto Superiore Di Sanita; 2020 [Internet]. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Report-COVID-2019_20_marzo_eng.pdfТомилина НА, Фролова НФ, Артюхина ЛЮ и др. COVID-19: связь с патологией почек. Обзор литературы. Нефрология и диализ 2021;23(2):147–159. doi: 10.28996/2618-9801-2021-2-147-159Tomilina NA, Frolova NF, Artyuhina LYU et al. COVID-19: relationship with kidney diseases. Literature review. Nephrology and dialysis 2021; 23(2):147–159 (In Russ.) doi: 10.28996/2618-9801-2021-2-147-159Кравченко АЯ, Концевая АВ, Будневский АВ, Черник ТА. Новая коронавирусная инфекция (COVID-19) и патология почек. Профилактическая медицина 2022;25(3):92–97Kravchenko AYa, Kontsevaya AV, Budnevsky AV, Chernik TA. Novel coronavirus infection (COVID-19) and kidney disease. Profilakticheskaya Meditsina 2022;25(3):92–97 (In Russ.) doi: 10.17116/profmed20222503192Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology 2020;52(6):1193–1194. doi: 10.1007/s11255-020-02451-9/Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. International Urology and Nephrology 2020;52(6):1193–1194. doi: 10.1007/s11255-020-02451-9/Suleyman G, Fadel RA, Malette KM et al. Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Network Open 2020;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270Suleyman G, Fadel RA, Malette KM et al. Clinical Characteristics and Morbidity Associated with Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Network Open 2020;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270Duarsa GWK, Sugianto R, Yusari IGAAA et al. Method for determining predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019 in a systematic review and meta-analysis research. MethodsX 2023;11:102250. doi: 10.1016/j.mex.2023.102250Duarsa GWK, Sugianto R, Yusari IGAAA et al. Method for determining predictor factor for worse outcomes in kidney transplant recipients infected with coronavirus disease 2019 in a systematic review and meta-analysis research. MethodsX 2023;11:102250. doi: 10.1016/j.mex.2023.102250Ghaffari Rahbar M, Nafar M, Khoshdel A et al. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22(5):e13406. doi: 10.1111/tid.13406Ghaffari Rahbar M, Nafar M, Khoshdel A et al. Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response? Transpl Infect Dis 2020;22(5):e13406. doi: 10.1111/tid.13406Caillard S, Anglicheau D, Matignon M et al. French SOT COVID Registry. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98(6):1549–1558. doi: 10.1016/j.kint.2020.08.005Caillard S, Anglicheau D, Matignon M et al. French SOT COVID Registry. An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int 2020;98(6):1549–1558. doi: 10.1016/j.kint.2020.08.005Santeusanio AD, Menon MC, Liu C et al. Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID-19). Clin Transplant 2021;35(4):e14221. doi: 10.1111/ctr.14221Santeusanio AD, Menon MC, Liu C et al. Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID-19). Clin Transplant 2021;35(4):e14221. doi: 10.1111/ctr.14221Zhang J, Pang Q, Zhou T et al. Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis. Ren Fail 2023;45(1):2170809. doi: 10.1080/0886022X.2023.2170809Zhang J, Pang Q, Zhou T et al. Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis. Ren Fail 2023;45(1):2170809. doi: 10.1080/0886022X.2023.2170809Chen YT, Shao SC, Hsu CK et al. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Crit Care 2020;24(1):346. doi: 10.1186/s13054-020-03009-yChen YT, Shao SC, Hsu CK et al. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Crit Care 2020;24(1):346. doi: 10.1186/s13054-020-03009-ySabaghian T, Kharazmi AB, Ansari A et al. COVID-19 and Acute Kidney Injury: A Systematic Review. Front Med (Lausanne) 2022;9:705908. doi: 10.3389/fmed.2022.705908Sabaghian T, Kharazmi AB, Ansari A et al. COVID-19 and Acute Kidney Injury: A Systematic Review. Front Med (Lausanne) 2022;9:705908. doi: 10.3389/fmed.2022.705908Zhen Li, Ming Wu, Jiwei Yao et al. Caution on Kidney Dysfunctions of COVID-19 Patients. MedRxiv preprint 2020;02.08.20021212; doi: https://doi.org/10.1101/2020.02.08.20021212Zhen Li, Ming Wu, Jiwei Yao et al. Caution on Kidney Dysfunctions of COVID-19 Patients. MedRxiv preprint 2020;02.08.20021212; doi: https://doi.org/10.1101/2020.02.08.20021212Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005Yang Q, Yang X. Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients. PLOS One 2020;15(11):e0241953. doi: 10.1371/journal.pone.0241953Yang Q, Yang X. Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients. PLOS One 2020;15(11):e0241953. doi: 10.1371/journal.pone.0241953Pei G, Zhang Z, Peng J et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol 2020;31(6):1157–1165. doi: 10.1681/ASN.2020030276Pei G, Zhang Z, Peng J et al. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. J Am Soc Nephrol 2020;31(6):1157–1165. doi: 10.1681/ASN.2020030276Столяревич ЕС, Фролова НФ, Артюхина ЛЮ, Варясин ВВ. Поражение почек при Covid-19: клинические и морфологические проявления почечной патологии у 220 пациентов, умерших от Covid-19. Нефрология и Диализ 2020;22 (Спецвыпуск):46–55. doi: 10.28996/2618-9801Stolyarevich ES, Frolova NF, Artyuhina LYU, Varyasin VV. Kidney damage in COVID-19: clinical and morphological manifestations of renal pathology in 220 patients died from COVID-19. Nephrology and Dialysis 2020;22 (Special Issue):46–55. doi: 10.28996/2618-9801Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507–513. doi: 10.1016/S0140-6736(20)30211-7Diao B, Wang C, Wang R et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun 2021;12(1):2506. doi: 10.1038/s41467-021-22781-1Diao B, Wang C, Wang R et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun 2021;12(1):2506. doi: 10.1038/s41467-021-22781-1Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3Chen T, Wu D, Chen H et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091. doi: 10.1136/bmj.m1091Chen T, Wu D, Chen H et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091. doi: 10.1136/bmj.m1091Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475–481. doi: 10.1016/S2213-2600(20)30079-5Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475–481. doi: 10.1016/S2213-2600(20)30079-5Arentz M, Yim E, Klaff L et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020;323(16):1612–1614. doi: 10.1001/jama.2020.4326Arentz M, Yim E, Klaff L et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020;323(16):1612–1614. doi: 10.1001/jama.2020.4326Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney 360 2021;3(2):242–257. doi: 10.34067/KID.0005342021Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney 360 2021;3(2):242–257. doi: 10.34067/KID.0005342021Hirsch JS, Ng JH, Ross DW et al. Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020;98(1):209–218. doi: 10.1016/j.kint.2020.05.006Hirsch JS, Ng JH, Ross DW et al. Northwell COVID-19 Research Consortium; Northwell Nephrology COVID-19 Research Consortium. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020;98(1):209–218. doi: 10.1016/j.kint.2020.05.006Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775Richardson S, Hirsch JS, Narasimhan M et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775Hobson CE, Yavas S, Segal MS et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119(18):2444–2453. doi: 10.1161/CIRCULATIONAHA.108.800011Hobson CE, Yavas S, Segal MS et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119(18):2444–2453. doi: 10.1161/CIRCULATIONAHA.108.800011Ng JH, Hirsch JS, Hazzan A et al. Northwell Nephrology COVID-19 Research Consortium. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis 2021;77(2):204–215.e1. doi: 10.1053/j.ajkd.2020.09.002Ng JH, Hirsch JS, Hazzan A et al. Northwell Nephrology COVID-19 Research Consortium. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury. Am J Kidney Dis 2021;77(2):204–215.e1. doi: 10.1053/j.ajkd.2020.09.002Sang L, Chen S, Zheng X et al. The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med 2020;20(1):290. doi: 10.1186/s12890020-01305-5Sang L, Chen S, Zheng X et al. The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med 2020;20(1):290. doi: 10.1186/s12890020-01305-5Chaudhri I, Moffitt R, Taub E et al. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19. Kidney Blood Press Res 2020;45(6):1018–1032. doi: 10.1159/000511946Chaudhri I, Moffitt R, Taub E et al. Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19. Kidney Blood Press Res 2020;45(6):1018–1032. doi: 10.1159/000511946Hultström M, Lipcsey M, Wallin E et al. Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care 2021;25(1):37. doi: 10.1186/s13054-021-03461-4Hultström M, Lipcsey M, Wallin E et al. Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care 2021;25(1):37. doi: 10.1186/s13054-021-03461-4Nugent J, Aklilu A, Yamamoto Y et al. Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19. JAMA Netw Open 2021;4(3):e211095. doi: 10.1001/jamanetworkopen.2021.1095Nugent J, Aklilu A, Yamamoto Y et al. Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19. JAMA Netw Open 2021;4(3):e211095. doi: 10.1001/jamanetworkopen.2021.1095Legrand M, Bell S, Forni L et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021;17(11):751–764. doi: 10.1038/s41581-021-00452-0Legrand M, Bell S, Forni L et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol 2021;17(11):751–764. doi: 10.1038/s41581-021-00452-0Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005Cheng Y, Luo R, Wang K et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005Chan L, Chaudhary K, Saha A et al. On behalf of the Mount Sinai COVID Informatics Center (MSCIC). AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol 2021;32(1):151–160. doi: 10.1681/ASN.2020050615Chan L, Chaudhary K, Saha A et al. On behalf of the Mount Sinai COVID Informatics Center (MSCIC). AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol 2021;32(1):151–160. doi: 10.1681/ASN.2020050615Temiz MZ, Hacibey I, Yazar RO et al. Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. Ren Fail 2022;44(1):233–240. doi: 10.1080/0886022X.2022.2032743Temiz MZ, Hacibey I, Yazar RO et al. Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. Ren Fail 2022;44(1):233–240. doi: 10.1080/0886022X.2022.2032743Filev R, Rostaing L, Lyubomirova M et al. COVID-19 Infection in Chronic Kidney Disease Patients in Bulgaria: Risk Factors for Death and Acute Kidney Injury. J Pers Med 2022;12(10):1676. doi: 10.3390/jpm12101676Filev R, Rostaing L, Lyubomirova M et al. COVID-19 Infection in Chronic Kidney Disease Patients in Bulgaria: Risk Factors for Death and Acute Kidney Injury. J Pers Med 2022;12(10):1676. doi: 10.3390/jpm12101676Ойноткинова ОШ, Мацкеплишвили СТ, Ларина ВН и др. Влияние SARS-CoV-2 на мультиорганное поражение и реабилитационная тактика в постковидном периоде. Кардиология и сердечно-сосудистая хирургия 2022;15(2):202–214. doi: 10.17116/kardio202215021202Oynotkinova OSh, Matskeplishvili ST, Larina VN et al. The effect of SARS-CoV-2 on multi-organ damage and rehabilitation tactics in the post-COVID period. Kardiologiya i Serdechno-Sosudistaya Khirurgiya 2022;15(2):202–214 (In Russ.) doi: 10.17116/kardio202215021202Борисова ОВ, Маковецкая ГА, Мазур ЛИ и др Пандемия COVID-19 и поражение почек у детей: обзор литературы и собственные региональные наблюдения. Медицинский Совет 2022;(1):134–141. doi: 10.21518/2079-701X-2022-161-134-141Borisova OV, Makovetskaya GA, Mazur LI et al. COVID-19 pandemic and kidney disease in children: literature review and own regional observations. Meditsinskiy sovet 2022;(1):134–141 (In Russ.) doi: 10.21518/2079-701X-2022-16-1-134-141Нуруллина ГИ, Халфина ТН, Исламова ГМ и др. Клинический случай острого повреждения почек у пациента с COVID-19. Практическая медицина 2022;20(1):129–132. doi: 10.32000/2072-1757-2022-1-129-132Nurullina GI, Khalfina TN, Islamova et al. Clinical case of acute kidney injury in a patient with COVID-19. Practical medicine 2022;20(1):129–132 (In Russ.) doi: 10.32000/2072-1757-2022-1-129-132Иванов ДД, Гоженко АИ, Иванова МД, Завальная ИН. Влияние COVID-19 на функцию почек у пациентов с артериальной гипертензией 1–2 степени и хронической болезнью почек. Нефрология 2022;26(1):34–43. doi: 10.36485/1561-6274-2022-26-1-34-43Ivanov DD, Gozhenko AI, Ivanova MD, Zavalnaya IN. Effect of COVID-19 on kidney function in patients with arterial hypertension grade 1–2 and CKD. Nephrology (Saint-Petersburg) 2022;26(1):34–43. (In Russ.) doi: 10.36485/1561-6274-202226-1-34-43Арутюнов ГП, Тарловская ЕИ, Арутюнов АГ и др. Клинические особенности постковидного периода. Результаты международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (АКТИВ SARS-CoV-2)». (12 месяцев наблюдения). Российский кардиологический журнал 2023;28(1):5270. doi: 10.15829/1560-4071-2023-5270Arutyunov GP, Tarlovskaya EI, Arutyunov AG et al. Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up). Russian Journal of Cardiology 2023;28(1):5270. (In Russ.) doi: 10.15829/1560-4071-2023-5270Ayoubkhani D, Khunti K, Nafilyan V et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021;372:n693. doi: 10.1136/bmj.n693Ayoubkhani D, Khunti K, Nafilyan V et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 2021;372:n693. doi: 10.1136/bmj.n693Chaolin H, Huang C, Huang L et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397(10270):220–232. doi: 10.1016/S0140-6736(20)32656-8Chaolin H, Huang C, Huang L et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397(10270):220–232. doi: 10.1016/S0140-6736(20)32656-8Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney 360 2021;3(2):242–257. doi: 10.34067/KID.0005342021Sun S, Annadi RR, Chaudhri I et al. Short- and Long-Term Recovery after Moderate/Severe AKI in Patients with and without COVID-19. Kidney 360 2021;3(2):242–257. doi: 10.34067/KID.0005342021Худякова АД, Каширина АП, Карасева АА и др. Почечная дисфункция и гиперурикемия у пациентов, перенесших новую коронавирусную инфекцию. Нефрология и диализ 2022;24(3):486–493. doi: 10.28996/2618-9801-2022-3-486493Hudyakova AD, Kashirina AP, Karaseva AA et al. Associations of renal dysfunction and hyperuricemia in patients with a new coronavirus infection. Nephrology and dialysis 2022;24(3):486–493. (In Russ.) doi: 10.28996/2618-9801-2022-3-486-493Chávez-Valencia V, Orizaga-de-la-Cruz C, LagunasRangel FA. Acute Kidney Injury in COVID-19 Patients: Pathogenesis, Clinical Characteristics, Therapy, and Mortality. Diseases 2022;10(3):53. doi: 10.3390/diseases10030053Chávez-Valencia V, Orizaga-de-la-Cruz C, LagunasRangel FA. Acute Kidney Injury in COVID-19 Patients: Pathogenesis, Clinical Characteristics, Therapy, and Mortality. Diseases 2022;10(3):53. doi: 10.3390/diseases10030053Pan XW, Xu D, Zhang H et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 2020;46(6):1114–1116. doi: 10.1007/s00134-020-06026-1Pan XW, Xu D, Zhang H et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 2020;46(6):1114–1116. doi: 10.1007/s00134-020-06026-1Su L, Zhang J, Peng Z. The role of kidney injury biomarkers in COVID-19. Ren Fail 2022;44(1):1280–1288. doi: 10.1080/0886022X.2022.2107544Su L, Zhang J, Peng Z. The role of kidney injury biomarkers in COVID-19. Ren Fail 2022;44(1):1280–1288. doi: 10.1080/0886022X.2022.2107544Алиева АМ, Теплова НВ, Резник ЕВ и др. Биомаркеры в кардиологии: липокалин, связанный с желатиназой нейтрофилов (NGAL), и сердечно-сосудистые заболевания. Терапия 2022; 8(1):50–59. doi: 10.18565/therapy.2022.1.50-59Alieva AM, Teplova NV, Reznik EV et al. Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases. Therapy 2022;8(1):50–59. (In Russ.) doi: 10.18565/therapy.2022.1.50-59Garganeeva AA, Kuzheleva EA, Fediunina VA et al. Low level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with chronic heart failure and multivessel coronary atherosclerosis. Russian Open Medical Journal 2022;11:e0102. doi: 10.15275/rusomj.2022.0102Garganeeva AA, Kuzheleva EA, Fediunina VA et al. Low level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with chronic heart failure and multivessel coronary atherosclerosis. Russian Open Medical Journal 2022;11:e0102. doi: 10.15275/rusomj.2022.0102Малярчиков АВ, Шаповалов КГ, Лукьянов СА и др. Острое почечное повреждение у больных пневмониями на фоне гриппа A/H1N1. Acta Biomedica Scientifica 2021;6(3):53– 59. doi: 10.29413/ABS.2021-6.3.5Malyarchikov AV, Shаpovаlov KG, Lukyanov SA et al. Acute kidney injury in patients with pneumonia with A/H1N1 influenza. Acta Biomedica Scientifica 2021;6(3):53–59. (In Russ.) doi: 10.29413/ABS.2021-6.3.5Stopic B, Medic-Brkic B, Savic-Vujovic K et al. Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease. Dose Response 2022;20(3):15593258221127568. doi: 10.1177/15593258221127568Stopic B, Medic-Brkic B, Savic-Vujovic K et al. Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease. Dose Response 2022;20(3):15593258221127568. doi: 10.1177/15593258221127568Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol 2021;17(2):81–82. doi: 10.1038/s41581-020-00381-4Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol 2021;17(2):81–82. doi: 10.1038/s41581-020-00381-4

The authors declare that there are no conflicts of interest present.